Schnabolk, Gloriane <br/><br/>
New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.  [electronic resource] 

 -  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics  06 2017 
 - 400-411 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-7732 
<br/><br/><label>Standard No.: </label>10.1089/jop.2016.0101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD59 Antigens--administration & dosage<br/>Choroidal Neovascularization--drug therapy<br/>Complement Inactivating Agents--administration & dosage<br/>Endothelial Cells--drug effects<br/>Injections, Intraperitoneal<br/>Lasers<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Receptors, Complement 3d--administration & dosage<br/>Retinal Pigment Epithelium--drug effects